Literature DB >> 15633405

PDR in juvenile onset diabetics: high-risk proliferative diabetic retinopathy in juvenile onset diabetics.

L J Singerman1, D T Weaver.   

Abstract

We analyzed the subgroup of juvenile diabetics with proliferative diabetic retinopathy (PDR). One hundred consecutive Diabetic Retinopathy Study (DRS) defined high-risk eyes were treated with argon laser photocoagulation. Mean age of diabetes onset was 8.1 years and mean duration was 15.9 years. Average follow-up was 36 months. All treatment failures resulting in severe visual loss (less than 5/200 vision) occurred in the second eye treated, in spite of our routinely treating the worse eye first. We delayed treating fellow eyes prior to the 1976 DRS report. We now consider prompt treatment of the fellow high-risk eye mandatory. Five patients (5.6%) suffered severe visual loss in three years compared to 10.5% in two years in the DRS for high-risk treated eyes. We conclude that more extensive treatment, perhaps 2500 to over 3000 500 micron lesions, further reduces incidence of severe visual loss beyond the reduction shown by the DRS.

Entities:  

Mesh:

Year:  1981        PMID: 15633405

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

1.  Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes.

Authors:  Chu-Hsuan Huang; Yi-Ting Hsieh; Chung-May Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-06       Impact factor: 3.117

2.  Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.

Authors:  G W Aylward; R V Pearson; J D Jagger; A M Hamilton
Journal:  Br J Ophthalmol       Date:  1989-03       Impact factor: 4.638

3.  Early vitrectomy for progressive diabetic proliferations covering the macula.

Authors:  R Grewing; U Mester
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.